← All organizations

Akashi Therapeutics

For profitWebsite ↗

Also known as: AkashiTherapeutics | Askashi Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 1, 2015

Timeline

2010s

Jun 1, 2012
Akashi Therapeutics— Founded

Drugs by trial phase (1 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

halofuginone

Indications

Studied for

Recent trials (6)

NCT02525302Study directorPhase 2May 1, 2015
NCT02525302Lead sponsorPhase 2May 1, 2015
NCT01978366Study directorPhase 2Oct 1, 2013
NCT01978366Lead sponsorPhase 2Oct 1, 2013
NCT01847573Study directorPhase 1/Phase 2May 1, 2013
NCT01847573Lead sponsorPhase 1/Phase 2May 1, 2013

Details

Founded: Cambridge, MA, US Jun 1, 2012
Last known activity: May 1, 2015